← Open Payments lookup

ROSEMARY SON: Open Payments

NPI 1609190503 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,305 in 45 payments from 13 companies in 2025. Trend: 2023 $4,044 · 2024 $6,069 · 2025 $7,305

Food & beverage: $2,964Consulting: $2,296Speaker / faculty: $1,910Travel & lodging: $135
CompanyPaymentsAmount
GENZYME CORPORATION9$2,603
Novartis Pharmaceuticals Corporation5$1,669
LEO Pharma Inc.5$1,173
Amgen Inc.6$599
Janssen Scientific Affairs, LLC3$278
UCB, Inc.3$247
Lilly USA, LLC3$216
Incyte Corporation3$159
Arcutis Biotherapeutics, Inc.2$146
ABBVIE INC.3$102

Products named: DUPIXENT, COSENTYX, ANZUPGO, OTEZLA, TREMFYA, Bimzelx, EBGLYSS, ADBRY.

Industry payments across TX — which companies pay providers there.